Arterial-wave reflections are increased in heart failure patients with a left-ventricular assist device

Richard S Schofield1, Gary L Pierce, Wilmer W Nichols

  • 1Department of Veterans Affairs Medical Center, Gainesville, Florida, USA. schofrs@medicine.ufl.edu

Insights

Left-ventricular assist device (LVAD) therapy increases central arterial pulse-wave reflections in heart failure patients, raising aortic augmented pressure and augmentation index. This hemodynamic load impacts LVAD management and device longevity.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Hemodynamics

Background:

  • Chronic heart failure (HF) is linked to elevated central arterial pulse-wave reflections, potentially increasing myocardial oxygen demand.
  • Left-ventricular assist device (LVAD) therapy is a common treatment for HF, but its impact on arterial pulse-wave reflections remains unstudied.

Purpose of the Study:

  • To investigate the effects of LVAD support on central arterial pulse-wave reflections in patients with end-stage heart failure.
  • To compare pulse-wave analysis data between LVAD patients, patients on inotropic drugs, and healthy controls.

Main Methods:

  • Central aortic pulse-wave analysis was conducted using the SphygmoCor system.
  • Data were collected from five end-stage HF patients on LVAD support, ten patients on intravenous inotropic drugs, and ten healthy controls.

Main Results:

  • LVAD patients exhibited higher aortic augmented pressure and augmentation index (AI(a)) compared to inotropic and control groups.
  • The AI(a) was significantly higher in LVAD patients (28.2%) versus inotropic patients (7.9%).
  • LVAD patients showed a significantly higher aortic systolic tension time index, indicating increased myocardial oxygen demand.

Conclusions:

  • LVAD support increases central arterial pulse-wave reflection in end-stage HF patients, elevating aortic augmented pressure and AI(a).
  • The elevated AI(a) in LVAD patients compared to healthy controls suggests a significant hemodynamic alteration.
  • Increased arterial wave reflection imposes a hemodynamic load on LVADs, potentially affecting device management and longevity.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...